LIFESPAN EXAM zm
Exam Solution
zm
NRNP 6665 Final Exam Test Questions NR 603 Week 7
zm zm zm zm zm zm zm zm zm zm
2026 A+ GRADE ASSURED COMPLETE SOLUTIONS AND
zm zm zm zm zm zm zm
VERIFIED ANSWERS (225CE) zm zm
QUESTION 1 zm
Question 18: Christine is a 9-year-
zm zm zm zm zm
old female who presents for care after having been placed in the local foster care syst
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
em. She has been in and out of foster care for the last 4 years after her parents were
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
killed in an automobile accident. Christine has been placed in a variety of homes and
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
residential care facilities. The PMHNP recognizes that Christine is at high risk for:
zm zm zm zm zm zm zm zm zm zm zm zm
ANSWER
A.
zm Dissociative disorders zm
B.
zm Post-traumatic stress disorder zm zm
C.
zm Impulse-control disorder zm
D.zm Attachment disorder zm
QUESTION 2 zm
Question 2: Debi is a 15-year- zm zm zm zm zm
old girl who is currently being treated for depression. Her parents have been very pr
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
oactive and involved in her care, and Debi has achieved remission 2 months after beg
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
inning treatment with a combination of pharmacotherapy and cognitive behavioral the
zm zm zm zm zm zm zm zm zm zm
rapy. While counseling Debi's parents about important issues in management, the PM
zm zm zm zm zm zm zm zm zm zm zm
HNP advises that:
zm zm
ANSWER
A. There is a > 50% likelihood that Debi's younger sibling will develop depressive symptoms
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
B. The mean length of major depressive episode in adolescents is 4 months
zm zm zm zm zm zm zm zm zm zm zm zm
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar I within 5 yea
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
rs
D. Adolescent-onset depression typically need long-
zm zm zm zm zm
term pharmacologic management to prevent relapses
zm zm zm zm zm
,QUESTION 3 zm
Agomelatine
ANSWER
Brand: Valdoxan -Melatonin multimodal (Mel-MM) -
zm zm zm zm zm
Agonist at melatonergic 1 and melatonergic 2 receptors -Antagonist at 5HT2C receptors -
zm zm zm zm zm zm zm zm zm zm zm zm
Not FDA approved: Rx for Depression, Generalized anxiety disorder -
zm zm zm zm zm zm zm zm zm
Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
QUESTION 4 zm
Amitriptyline (Elavil) zm
ANSWER
Tricyclic antidepressant.zm
QUESTION 5 zm
Aripiprazole (Abilify) zm
ANSWER
Treatment for depression. Atypical antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonis
zm zm zm zm zm zm zm zm zm
t in high concentration and also stimulates increase of dopamine in low concentrations. Side effects:
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
insomnia, akathisia. zm
QUESTION 6 zm
Brexpiprazole (Rexulti) zm
ANSWER
Treatment for depression. Atypical antipsychotic
zm zm zm zm
QUESTION 7 zm
Bupropion (Wellbutrin) zm
ANSWER
Antidepressant and smoking cessation aid, It can treat depression and help people quit smoking. It c
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
an also prevent depression caused by seasonal affective disorder (SAD).
zm zm zm zm zm zm zm zm zm
QUESTION 8 zm
Citalopram (Celexa) zm
, ANSWER
Antidepressant, SSRI: 20-40 mg qd. zm zm zm zm
QUESTION 9 zm
Cyamemazine (Tercian) zm
ANSWER
Treatment for depression. -Known as cyamepromazine -
zm zm zm zm zm zm
Typical antipsychotic drug of the phenothiazine class. -Treatment for schizophrenia and psychosis-
zm zm zm zm zm zm zm zm zm zm zm
associated anxiety -Behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-
zm zm zm zm zm zm zm zm zm zm zm zm zm
HT2C) and lack of extrapyramidal side effects (5-HT2A). -
zm zm zm zm zm zm zm zm
Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, serotonin dopamine a
zm zm zm zm zm zm zm zm zm
ntagonist) -Commonly Prescribed for (not FDA approved): -Schizophrenia -
zm zm zm zm zm zm zm zm
Anxiety associated with psychosis (short-term) -
zm zm zm zm zm
Anxiety associated with nonpsychotic disorders, including mood disorders and personality disorders
zm zm zm zm zm zm zm zm zm zm zm
(short-term) -Severe depression -Bipolar disorder -Other psychotic disorders -
zm zm zm zm zm zm zm zm
Acute agitation/aggression (injection) -Benzodiazepine withdrawal
zm zm zm zm
QUESTION 10 zm
Desiprimine (Norpramine) zm
ANSWER
Treats depression Brand: Norpramin -TCA -Norepinephrine noradrenaline reuptake inhibitor. -
zm zm zm zm zm zm zm zm zm
FDA approved for treating depression. -Off-
zm zm zm zm zm
label: Anxiety, Insomnia, Neuropathic pain/chronic pain, Treatment-resistant depression. -
zm zm zm zm zm zm zm zm
More potent inhibitor of norepinephrine reuptake pump than serotonin reuptake pump (serotonin tr
zm zm zm zm zm zm zm zm zm zm zm zm
ansporter). -May have immediate effects in treating insomnia or anxiety. -
zm zm zm zm zm zm zm zm zm zm
If it is not working within 6-
zm zm zm zm zm zm
8 weeks for depression, it may require a dosage increase or it may not work at all -100-
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
200 mg/day (for depression) 50-150 mg/day (for chronic pain).
zm zm zm zm zm zm zm zm
QUESTION 11 zm
Desvenlafaxine (Pristiq) zm
ANSWER
Dual serotonin and norepinephrine reuptake inhibitor-often classified as an antidepressant. -
zm zm zm zm zm zm zm zm zm zm
FDA approved to tx MDD. -Off-
zm zm zm zm zm
label: Vasomotor sx's, fibromyalgia, GAD, Social Anx d/o, panic d/o, PTSD, PMDD -
zm zm zm zm zm zm zm zm zm zm zm zm
Dopamine is inactivated by norepinephrine reuptake in frontal cortex (which lack dopamine transpo
zm zm zm zm zm zm zm zm zm zm zm zm
rters) med can increase dopamine neurotransmission in this part of the brain -
zm zm zm zm zm zm zm zm zm zm zm zm
QUESTION 12 zm
Exam Solution
zm
NRNP 6665 Final Exam Test Questions NR 603 Week 7
zm zm zm zm zm zm zm zm zm zm
2026 A+ GRADE ASSURED COMPLETE SOLUTIONS AND
zm zm zm zm zm zm zm
VERIFIED ANSWERS (225CE) zm zm
QUESTION 1 zm
Question 18: Christine is a 9-year-
zm zm zm zm zm
old female who presents for care after having been placed in the local foster care syst
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
em. She has been in and out of foster care for the last 4 years after her parents were
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
killed in an automobile accident. Christine has been placed in a variety of homes and
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
residential care facilities. The PMHNP recognizes that Christine is at high risk for:
zm zm zm zm zm zm zm zm zm zm zm zm
ANSWER
A.
zm Dissociative disorders zm
B.
zm Post-traumatic stress disorder zm zm
C.
zm Impulse-control disorder zm
D.zm Attachment disorder zm
QUESTION 2 zm
Question 2: Debi is a 15-year- zm zm zm zm zm
old girl who is currently being treated for depression. Her parents have been very pr
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
oactive and involved in her care, and Debi has achieved remission 2 months after beg
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
inning treatment with a combination of pharmacotherapy and cognitive behavioral the
zm zm zm zm zm zm zm zm zm zm
rapy. While counseling Debi's parents about important issues in management, the PM
zm zm zm zm zm zm zm zm zm zm zm
HNP advises that:
zm zm
ANSWER
A. There is a > 50% likelihood that Debi's younger sibling will develop depressive symptoms
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
B. The mean length of major depressive episode in adolescents is 4 months
zm zm zm zm zm zm zm zm zm zm zm zm
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar I within 5 yea
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
rs
D. Adolescent-onset depression typically need long-
zm zm zm zm zm
term pharmacologic management to prevent relapses
zm zm zm zm zm
,QUESTION 3 zm
Agomelatine
ANSWER
Brand: Valdoxan -Melatonin multimodal (Mel-MM) -
zm zm zm zm zm
Agonist at melatonergic 1 and melatonergic 2 receptors -Antagonist at 5HT2C receptors -
zm zm zm zm zm zm zm zm zm zm zm zm
Not FDA approved: Rx for Depression, Generalized anxiety disorder -
zm zm zm zm zm zm zm zm zm
Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
zm zm zm zm zm zm zm zm zm zm zm zm zm zm
QUESTION 4 zm
Amitriptyline (Elavil) zm
ANSWER
Tricyclic antidepressant.zm
QUESTION 5 zm
Aripiprazole (Abilify) zm
ANSWER
Treatment for depression. Atypical antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonis
zm zm zm zm zm zm zm zm zm
t in high concentration and also stimulates increase of dopamine in low concentrations. Side effects:
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
insomnia, akathisia. zm
QUESTION 6 zm
Brexpiprazole (Rexulti) zm
ANSWER
Treatment for depression. Atypical antipsychotic
zm zm zm zm
QUESTION 7 zm
Bupropion (Wellbutrin) zm
ANSWER
Antidepressant and smoking cessation aid, It can treat depression and help people quit smoking. It c
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
an also prevent depression caused by seasonal affective disorder (SAD).
zm zm zm zm zm zm zm zm zm
QUESTION 8 zm
Citalopram (Celexa) zm
, ANSWER
Antidepressant, SSRI: 20-40 mg qd. zm zm zm zm
QUESTION 9 zm
Cyamemazine (Tercian) zm
ANSWER
Treatment for depression. -Known as cyamepromazine -
zm zm zm zm zm zm
Typical antipsychotic drug of the phenothiazine class. -Treatment for schizophrenia and psychosis-
zm zm zm zm zm zm zm zm zm zm zm
associated anxiety -Behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-
zm zm zm zm zm zm zm zm zm zm zm zm zm
HT2C) and lack of extrapyramidal side effects (5-HT2A). -
zm zm zm zm zm zm zm zm
Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, serotonin dopamine a
zm zm zm zm zm zm zm zm zm
ntagonist) -Commonly Prescribed for (not FDA approved): -Schizophrenia -
zm zm zm zm zm zm zm zm
Anxiety associated with psychosis (short-term) -
zm zm zm zm zm
Anxiety associated with nonpsychotic disorders, including mood disorders and personality disorders
zm zm zm zm zm zm zm zm zm zm zm
(short-term) -Severe depression -Bipolar disorder -Other psychotic disorders -
zm zm zm zm zm zm zm zm
Acute agitation/aggression (injection) -Benzodiazepine withdrawal
zm zm zm zm
QUESTION 10 zm
Desiprimine (Norpramine) zm
ANSWER
Treats depression Brand: Norpramin -TCA -Norepinephrine noradrenaline reuptake inhibitor. -
zm zm zm zm zm zm zm zm zm
FDA approved for treating depression. -Off-
zm zm zm zm zm
label: Anxiety, Insomnia, Neuropathic pain/chronic pain, Treatment-resistant depression. -
zm zm zm zm zm zm zm zm
More potent inhibitor of norepinephrine reuptake pump than serotonin reuptake pump (serotonin tr
zm zm zm zm zm zm zm zm zm zm zm zm
ansporter). -May have immediate effects in treating insomnia or anxiety. -
zm zm zm zm zm zm zm zm zm zm
If it is not working within 6-
zm zm zm zm zm zm
8 weeks for depression, it may require a dosage increase or it may not work at all -100-
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm
200 mg/day (for depression) 50-150 mg/day (for chronic pain).
zm zm zm zm zm zm zm zm
QUESTION 11 zm
Desvenlafaxine (Pristiq) zm
ANSWER
Dual serotonin and norepinephrine reuptake inhibitor-often classified as an antidepressant. -
zm zm zm zm zm zm zm zm zm zm
FDA approved to tx MDD. -Off-
zm zm zm zm zm
label: Vasomotor sx's, fibromyalgia, GAD, Social Anx d/o, panic d/o, PTSD, PMDD -
zm zm zm zm zm zm zm zm zm zm zm zm
Dopamine is inactivated by norepinephrine reuptake in frontal cortex (which lack dopamine transpo
zm zm zm zm zm zm zm zm zm zm zm zm
rters) med can increase dopamine neurotransmission in this part of the brain -
zm zm zm zm zm zm zm zm zm zm zm zm
QUESTION 12 zm
